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Generalized Hexokinase Deficiency in the Blood Cells of a Patient
With Nonspherocytic Hemolytic Anemia
By G. Rijksen, J. W. N. Akkerman, A. W. L. van den Wall Bake, D. Pott Hofstede, and G. E. J. Staal
In a patient with nonspherocytic hemolytic anemia. a
hexokinase deficiency was detected in the red cells (resid-
ual activity about 25% of normal) and in blood platelets
(20%-35% of normal activity). Although the total hexoki-
nase activity in lymphocytes was normal. the amount of
hexokinase type I was decreased to about 50% of normal.
However. the deficiency was compensated for by the
appearance of type III hexokinase. Compartmentation
studies with controlled digitonin-induced cell lysis showed
that this type III enzyme was localized in the cytosol. while
almost all hexokinase activity in normal lymphocytes is
particulate. No abnormal lymphocyte functions could be
detected. The patient was homozygous for the defect. The
H EXOKINASE (ADP: D-hexose-6-phosphotrans-
ferase, EC 2.7. 1 . 1 , HK) is one of the rate-
limiting enzymes in erythrocyte glycolysis. The key
role of HK in red cell metabolism is illustrated by the
manifestation of severe nonspherocytic hemolytic ane-
mia (NSHA) in subjects with a partial deficiency of
this enzyme. About ten families with HK-deficient
members suffering from NSHA have been reported, as
recently reviewed by Paglia et al.’ Mutations affecting
the substrate affinities of the enzyme,25 regulatory
properties,6 or heat stability2’78 have been described.
Other variants only show a decreased enzyme activity
with no additional enzyme abnormalities.9” In all
these patients the deficiency affected type I HK, the
predominant isoenzyme of HK in mammalian tissues.
In spite of the presence of mitochondnial energy
generation, 2 lymphocytes, ‘￿ and granulo-
cytes’5 all depend more or less heavily on energy
supplied by glycolysis. HK is therefore a likely candi-
date to play an essential role in the energy metabolism
of these cells too. Yet, HK deficiency manifests itself
primarily in NSHA, although in some patients a
diversity of abnormalities, including multiple malfor-
mations, panmyelopathy, and latent diabetes melli-
tus’6”7 have been described. The metabolic defects in
these patients, however, appear to be acquired rather
From the Department of Haematology, Division of Medical
Enzymology, State University Hospital. Utrecht, and the Depart-
ment of Internal Medicine, Hospital “Het Diakonessenhuis, “ Hil-
versum, The Netherlands.
Submitted March 15, 1982; accepted June JO, 1982.
Address reprint requests to Dr. G. Rijksen, Department of
Haematology, Division of Medical Enzymology, State University
Hospital, 3500 CG Utrecht, The Netherlands.
© I 983 by Grune & Stratton. Inc.
0006-4971/83/6101-0002$O1.OO/O
parents and three of five sibs of the patient were appar-
ently heterozygous with residual activities of 50%-67% of
normal in their red cells, but did not show any clinical signs
of hexokinase deficiency. The variant enzyme had a slightly
decreased affinity for MgATP￿ and a strongly increased
inhibition constant for glucose-i .6-P2. Affinity for glucose.
heat stability. and pH optimum were normal. In the electro-
phoretic pattern of red cell hexokinase. only one subtype of
hexokinase I could be detected. while in normal red cells. at
least three subtypes are present. In the heterozygous
individuals. no enzymatic abnormalities could be detected.
except for an aberration in the electropherogram of one
sib.
than truly genetic. One patient with a heterozygous
expression of HK deficiency showed an undefined
abnormality in the immune response.5
Some years ago we described a Dutch patient with
NSHA associated with HK deficiency.6 The mutant
enzyme was characterized by a decreased affinity for
the inhibitor glucose- 1,6-diphosphate (Glc-l ,6-P2) and
an absent regulation by inorganic phosphate. Some
minor abnormalities were found in the type I region of
the electrophoretic pattern. In this report we describe a
new apparently unrelated patient with NSHA and HK
deficiency. We studied the intracellular localization,
the kinetic and electrophoretic properties of the
mutant enzyme in erythrocytes, as well as in lympho-
cytes and platelets.
CASE REPORT
The proband was a 19-yr-old woman, anemic since birth, with
marked reticulocytosis and variable hyperbilirubinemia. In early
infancy, several blood transfusions were necessary. At the age of 2
yr. splenectomy was performed, after which the hemoglobin stabi-
lized at 6 mmole/liter. At the age of I 5, cholecystectomy was
performed; a liver biopsy taken peroperatively showed massive iron
storage. The etiology of the hemolytic anemia remained uncertain
until the time of the present investigations: a hexokinase deficiency
was detected as the possible cause of the hemolytic anemia. The most
recent hematologic data of the patient are shown in Table 1. The
patient was slightly anemic with a pronounced reticulocytosis and an
increased mean corpuscular volume and mean corpuscular hemoglo-
bin. In the blood smear, 2-25 normoblasts/lOO white cells and a
moderate polychromasia were observed. A few spherocytes and
Howell-iolly bodies were present. A marked leukocytosis and throm-
bocytosis was found. Haptoglobin was low; the amount of HbF was
slightly increased. The bone marrow showed a very active macro-
cytic erythropoiesis and an increased megakaryopoiesis.
Immunologic response in the patient appeared normal: serum
1gM, IgG, and IgA levels were slightly elevated. The numbers of B
and T lymphocytes were normal. The in vitro proliferative response
of the blood lymphocytes on mitogens (PHA, Con-A, and PWM)
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Table 1 . Routine Hem atologic Data
Patient Normals 191
Erythrocytes (x 1O’2/Iiter)
Hemoglobin(g/dI)
Haptoglobin (mg/dl)
Fetal hemoglobin (%)
Packed cell volume (ml/100 ml)
Mean corpuscular volume (fi)
Mean corpuscul￿ hemoglobin (pg)
Mean corpuscular hemoglobin
concentration (gil#{174} ml erythro-
cytes)
Reticulocytes (%)
Leukocytes(xlO9/Iiter)
Blood platelets (x 109/Iiter)
2.33
9.82
10
2.4
30
1 34
42.0
31.1
50
17.8
475
3.7-5.0
11.9-15.5
30-240
0.1-1.5
36-46
84-104
28.2-35.7
32.2-37
0.4-1.8
4-10
150-300
and an antigenic stimulation (tetanus-toxoid) was normal. In the
mixed lymphocyte culture, the lymphocytes behaved normally.5.
The father and mother of the patient were first cousins. The blood
pictures of the parents and of five sibs of the patient were normal,
except for a slight and unexplained leukopenia in the mother on one
occasion.
MATERIALS AND METHODS
Venous blood from the patient, relatives, and controls was
collected in either heparin (30 U/mI) or acid-citrate-dextrose
(ACD, fInal citrate concentration 13 mM). Within 1 hr after
collection of the blood a part of it was deproteinized for the
determination of glycolytic intermediates. Deproteinization and
determination of glycolytic intermediates were performed according
to the methods of Minakami et al.,’8 except for 2,3-diphosphoglycer-
ate (2,3-DPG) and adenosine triphosphate (AlP), which were
determined with Sigma (St. Louis, Mo.) test kits (Sigma Technical
Bulletin 35-UV and 366-UV, respectively).
Red cells were isolated by filtration of whole blood through an
a-cellulose-cristalline cellulose ￿ For kinetic and electro-
phoretic experiments, red cell HK was partially purified by batch-
wise treatment with DEAE-cellulose A 50 (Pharmacia, Uppsala,
Sweden) and concentrated by ammonium sulphate precipitation as
described before.￿#{176} The precipitate was dissolved in 0.2 M Tris-HCI,
pH 7.8, containing 3 mM fl-mercaptoethanol, and extensively dia-
lyzed against the same buffer.
Platelets were isolated from freshly collected ACD-blood by
centrifugation (10 mm, 200 g, 22#{176}C) and subsequent gel filtration of
the platelet-rich plasma.12
Lymphocytes were isolated from fresh human blood collected in
either ACD or heparin. After density centrifugation (20 mm, 1000
g, 22#{176}C) of the blood on Ficoll-Isopaque (Pharmacia, Uppsala,
Sweden, density 1.077), the lymphocytes were carefully collected
from the interface and treated with ammonium chloride (0.83%).
Monocytes were removed by adherence to plastic Petri dishes. The
resulting cell preparation consisted of >95% lymphocytes.
Cytosolic and bound HK were separated by discontinuous gra-
dient centrifugation after controlled digitonin-induced cell lysis as
described for human platelets by Akkerman et al.21 This procedure
enables the isolation ofcytosol and particulate fractions within 1 mm
after cell lysis. In an Eppendorf Microfuge centrifugation tube the
following gradient was established: lower layer, 100 ￿.xl Ca-free
Tyrode solution containing 10% v/v glycerol; middle layer, 250 ￿zl
(platelets) or 500 .tl (lymphocytes) of a 3:2 (v/v) mixture of
dibutylphtalate and dinonylphtalate (Merck, Darmstadt, G.F.R.);
and upper layer, 500 ￿zl cell suspension. To the upper layer, 50 jzl of a
digitonin suspension (Merck, Darmstadt, G.F.R.) was then added in
various concentrations and mixed. This procedure was adapted for
the fractionation of lymphocytes. The digitonin concentration ena-
bling maximal liberation of cytosolic lactate dehydrogenase (EC
1.1 .1.27, LDH) (>90%) and minimal leakage ofglutamate dehydro-
genase (EC I .4. 1.2, Glu-DH) was dependent on cell type and cell
concentration. This optimal digitonin concentration was determined
for each cell type by titrating with increasing amounts ofdigitonin at
standard cell concentrations.
After incubation of 10 sec (platelets) or 20 sec (lymphocytes) with
the digitonin, the suspension was centrifuged (45 sec. 10,000 g) in an
Eppendorf Microfuge equipped with a swingout rotor. Upper layer
and lower layer were collected and analyzed. To the lower layer, 400
zl of Ca-free Tyrode was added and the pellet was suspended by
mixing with a Vortex whirlmixer. The fractions were analyzed for
the activities of HK, LDH as a marker for the cytosol fractions, and
Glu-DH as a marker for the mitochondrial matrix. Percentages of
HK activity in cytosol and particulate fraction were corrected for the
percentage of non-cell lysis as based on the LDH activity in the pellet
fraction. Recoveries of total activity in pellet plus supernatant
fractions ranged from 90% to I 10%.
The erythrocyte glycolytic enzymes were determined according to
Beutler,’9 and Glu-DH according to Schmidt.22 Hexokinase was
measured at 37#{176}C in a glucose-6-phosphate coupled assay as
described previousIy.￿#{176} HK activities are expressed either in units per
gram hemoglobin or in milliunits per 10’ cells. Activities of HK and
GIu-DH in total cell lysates or in pellet fractions were determined
after incubation with 0.5% Triton X-lOO. The enzyme activities were
unaffected by either digitonin or Triton X-lOO.
HK electrophoresis on cellulose acetate gels and subsequent
staining for enzyme activity was performed as described before.23
Prior to electrophoresis, H K from particulate fractions was solubi-
lized by incubation with 0.5 M KCI (20 mm, 20#{176}C) and isolated by
subsequent centrifugation (I 5 mm, 48,000 g, 4#{176}C).
RESULTS
Erythrocyte Metabolism
In the erythrocytes of the patient, the absolute
activity of HK was normal or near the lower limit of
normal, when compared to normal controls. However,
the activities of the other cell age-dependent
enzymes-pyruvate kinase and glucose-6-phosphate
dehydrogenase-were strongly increased (Table 2),
which argues for a relative HK deficiency in the
patient. All other glycolytic enzymes were normal or
slightly increased (aldolase).
The activities of the erythrocyte glycolytic enzymes
in the immediate family were determined also. The
parents and three of the sibs (A.Z., H.G.Z., and C.Z.)
were found to be heterozygous for the defect. They
showed decreased HK activities ranging from 50% to
67% of normal. The other glycolytic enzymes in these
subjects were in the normal range.
Some abnormalities could be detected in the con-
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Table 2. Erythrocyte Enzyme Activities in Patient. Relatives. and Controls
Subject Hexokinase Pyruvate Kinase Glucose-6-P Dehydrogenase
Patient
Father
Mother
SisterA.Z.
BrotherE.W.Z.
BrotherH.G.Z.
SisterM.Z.
SisterC.Z.
Normals
Enzyme activities are expre ssed in units
0.99 ± 0.19 (4) 27.4 ± 3.8 (4) 22.1 ± 3.5 (3)
0.69 11.1 13.7
0.89 10.9 12.4
0.64 10.8 12.8
1.38 10.3 13.8
0.66 9.9 12.4
1.22 12.0 12.9
0.68 13.5 13.0
1.34 ± 0.42 (40) 13.5 ± 3.0 (40) 10.2 ± 3.3 (40)
per ￿‘am hemoglobin. The numbers in parenthesis indicate the number of determinations on different
samples.
tents of glycolytic intermediates in the patient’s eryth-
rocytes. The concentrations of glucose-6-P, fructose-
6-P were decreased, 2,3-diphosphoglycerate was
slightly below the lower limit or normal, whereas ATP
was even above the upper limit of normal. Fructose-
I ,6-diphosphate content was normal (Table 3). How-
ever, when the high degree of reticulocytosis in the
patient is taken into account, the levels of all these
metabolites are probably markedly decreased as a
result of the hexokinase deficiency.6
Hexokinase Activity and Compartmentation
in Lymphocytes and Blood Platelets
The activities of hexokinase were also studied in the
lymphocytes and blood platelets of the patient. The
results are summarized in Table 4. A deficiency of HK
was also found in blood platelets. The residual activity
was 209’o-30% of normal. Essentially all this activity
was bound to the particulate fraction, as is found in
normal platelets.
The total HK activity in the patient’s lymphocytes
was completely normal. However, its distribution
between soluble and particulate fractions had been
changed. In normal lymphocytes, over 78% of total
activity is bound to the mitochondrial membrane,
whereas in the patient’s lymphocytes there was a
considerable shift to the cytosolic fraction: only 42% of
total activity was found in the pellet fraction.
Table 3. Erythrocyte Glycolytic Intermediates
Patient Normals In - 20)
Glucose-6-P 27.5 35.7 ± 6.6
Fructose-6-P 8.4 13.6 ± 2.5
Fructose-1,6-di-P 6.6 5.1 ± 1.7
Glyceraldehyde-P 6.6 4.8 ± 1.6
2,3-Diphosphoglycerate 4,800 5,300 ± 400
3-P-glycerate 100.6 55 ± 35
2-P-glycerate 14.3 9.1 ± 5.3
2-P-enolpyruvate 22.2 13.4 ± 8.0
AlP 1 . 700 1 400 ± 200
Concentrations are expressed in nanomoles per milliliter erythrocytes.
Enzyme Properties
Kinetics. The kinetic properties of partially pun-
fled erythrocyte HK are summarized in Table 5. The
Km glucose of the patient’s enzyme was completely
normal; the Km MgATP was somewhat increased. The
inhibition constant for the inhibitor Glc- 1,6-P2 varied
from sample to sample, but was always between 3 and
10 times normal values. No kinetic abnormalities could
be detected in the partially purified preparations from
heterozygous subjects. The abnormal behavior of the
erythrocyte enzyme of the patient towards the inhibi-
ton Glc- 1,6-P2 was also detected for the platelet
enzyme (Fig. 1). A marked decrease in inhibition was
observed.
Heat stability. The heat stabilities of partially
purified erythrocyte hexokinase from patient, hetero-
zygotes, and controls at 44#{176}C were not significantly
different. Half of activity was lost between 3 and 4 mm
of incubation at 44#{176}C.
pH Optimum. A broad pH optimum was found,
ranging from pH 6.7 to 8.4 for patient, as well as for
heterozygotes and controls.
Electrophoresis. Cellulose acetate electrophoresis
of partially purified HK from normal erythrocytes
shows a multibanded pattern in the “type I region.”
Two subtypes are clearly visible, but more subtypes
can be discerned after separation by phosphocellulose
chromatography.24 Electrophoresis of the patient’s
Table 4. Hexokinase Activity and Compartmentation in
Lymphocytes and Platelets
Patient Normals
Lymphocytes
Activity
(mU/10’cells) 2.55 2.59 ±0.80(21)
Percentbound 42 78.1 ± 11.3 (12)
Platelets
Activity
(mU/1O6 cells) 0.041 ± 0.005 (3) 0.160 ± 0.039 (31)
Percentbound 95.2 88.5 ± 4.1 (13)
The numbers in peren thesis in dicate the num ber of determinations.
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Table 5. Properties of Partially Purified Red Cell Hexokinase
Patient Controls
K,, glucose (mM)
(M9ATP2 5 mM) 0.052 ± 0.007 (3) 0.062 ± 0.014 (5)
K￿MgATP2 (mM)
(glucose 10 mM) 1.28 ± 0.15 (5) 0.71 ± 0.09 (7)
K,GIc-1.6-P2(mM) 0.14 - 0.22 - 0.40t 0.045 ± 0.015 (7)
Heat stability Normal
pH Optimum Normal
Electrophoresis Altered
The K, Glc-1,6-P2 was determined at 10 mM glucose and varying
MgATP2 concentrations (0.3-5.0 mM) at pH 7.15 and 37#{176}C. Excess
of Mg2￿ over AlP was kept at 5 mM in all conditions.
tEach value represents the result of a separate experiment on different
blood samples.
enzyme showed only the most anodal subtype of HK I
(Fig. 2). Remarkably, the same pattern was seen in one
of the heterozygous sibs (C.Z.), while the other hetero-
zygotes were not discernable from normal.
In normal human lymphocytes, type I HK was
predominant, the major part of it being localized in the
particulate fraction. No subtypes of HK I were seen.
Mitochondnial HK consisted exclusively of the type I
isozyme. In the cytosol, circa 20% of total activity was
present, distributed between type I (50%-75%) and
type III HK (25%-50%). Thus, the contribution of
type III HK to the total activity did not exceed
5%-lO%. As type III HK is known to be inhibited by
high concentrations of glucose,25 its position in the
electropherogram was identified by the insertion of
100 mM glucose in the staining mixture, resulting in a
marked reduction in staining intensity (results not
shown). In the lymphocytes of the HK-deficient
patient, the activity was about equally distributed
Fig. 2. Cellulose acetate dee-
trophoresis of partially purified
erythrocyte hexokinase from normal
controls (C). present patient (J.Z.).
and heterozygous family members
(H.G.Z. and C.Z.).
+
#{149}1. residual
Qi 0.2 Q3 c14
[Gic.-1,6￿-P2](mM)
Fig. 1 . Inhibition of platelet HK (total cell Iysates) from patient
(0) and control (#{149}) by Glc-1.6-P2 at 0.35 mM MgATP￿ and 7 mM
glucose (pH 7.15. 37’C).
between type I and type III HK. Type I was found
exclusively in the particulate fraction, while type III
was localized in the cytosol. The results are shown in
Fig. 3.
DISCUSSION
The age dependency of HK in human erythrocytes is
well documented now even in quantitative terms.’8”
Although the absolute HK activity in the present
patient with nonspherocytic hemolytic anemia is about
normal, it can be concluded that the activity is only
hkl
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+
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I Q 3 4 5 3 4 5
III
Fig. 3. Cellulose acetate electro-
phoresis of lymphocyte hexokinase:
(1 ) normal control. bound fraction
after solubilization; (2) normal con-
trol. soluble fraction; (3) patient. total
activity fraction; (4) patient. bound
fraction after solubilization; (5) pa-
tient, soluble fraction. For the sake of
clarity. a diagram is added to the
electropherogram of the patient’s
samples.
about 25% of normal, when the degree of reticulocyto-
sis and the activities of the age-dependent enzymes
pyruvate kinase and glucose-6-phosphate dehydroge-
nase are taken into account. The HK activity in the
patient is even higher than in the apparently heterozy-
gous parents and sibs. The HK activities in these
heterozygous individuals vary between 50% and 70%
of normal, while no clinical symptoms of this partial
deficiency can be detected. Three of six children are
apparently heterozygous; one is homozygous for the
deficient trait. As HK deficiency is very rare and as the
parents are consanguineous, it is very probable that the
patient is a true homo￿ygote, rather than compound
heterozygous for two different mutations. It can be
concluded that the inheritance of HK deficiency is
autosomal recessive, in accordance with most data in
the literature. In some studies a dominant mode of
inheritance was suggested.3’8 However, it seems proba-
ble that in these studies patients were investigated with
a moderate clinical expression of a heterozygous state,
as in the study of Siimes et al.5 The residual activities
of red cell HK in those patients was about 40%-50% of
normal. The impact of HK deficiency on red cell
metabolism in our patient is rather difficult to evaluate
because of the young mean cell age. Glucose-6-P and
fructose-6-P are slightly lowered; 2,3-diphosphoglyc-
erate is low normal; while ATP concentration is above
the upper limit of normal. However, it is probably
reasonable to conclude that due to the HK deficiency,
the concentration of all these compounds is strongly
decreased with respect to the high reticulocytosis.6
Some years ago we described the first Dutch patient
with nonspherocytic hemolytic anemia associated with
HK deficiency.6 In this case the mutant enzyme was
characterized by a decreased affinity for the inhibitor
GIc- I ,6-P2, an absence of regulation by inorganic
phosphate, and a slightly abnormal electrophoretic
pattern in the “type I region.” The Km for MgATP2
was slightly increased too. In the present patient, some
of the enzymic abnormalities were similar: an
increased Km MgATP2 and an increased K1 Glc-
I ,6-P2 were found. However, the regulation of the
inhibition by hexose-phosphates by inorganic phos-
phate was normal (results not shown) and the electro-
phonetic pattern differed from the former patient. In
the present case only the most anodal subtype of HK I
was present, while in the former patient, two of three
subtypes of normal H K I were visible in the electropho-
retic pattern. In the heterozygous subjects no enzyme
abnormalities, except an aberrant electropherogram in
one, could be detected.
Although no family relationship between both
patients could be demonstrated up to now, ancestors of
both could be traced to the same rural village. There-
fore, and because of the rarity of the defect, it is very
likely that the same variant is expressed in both
patients, although differences in enzyme properties
exist. Direct evidence, however, is still lacking. It was
argued that the mutant enzyme in the first patient was
subject to increased posttranslational modification of
the primary enzyme.6 The differences in the enzyme
properties between the two deficient subjects probably
reflect a phenotypic or genotypic variation of these
processes. In this respect, the aberrant electrophoretic
pattern in one of the heterozygous sibs (C.Z.) is of
particular interest.
The study of HK deficiency has been mostly
restricted to the red cell. However, as the deficiency
concerns the most abundant isoenzyme type I HK, it
probably affects other cell types too. As platelets’2 and
314 are strongly dependent on glycolysis
for a proper performance of cell functions, we investi-
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gated the impact of HK deficiency on these cell types.
HK activity in the lymphocytes of the patient was
normal. Yet, the amount of type I HK was only about
50% of normal. However, the deficiency was compen-
sated for by the appearance of type III HK, which is
present in only minor quantities (5%-10%) in normal
lymphocytes. Type Ill HK has a higher affinity for
glucose than the type I isoenzyme and is inhibited by
high concentrations of glucose.25 In normal lympho-
cytes, most of the HK activity is found in the particu-
late fractions, presumably bound to the mitochondnia.
The localization of HK on the mitochondnial mem-
brane was suggested to play a key role in the mainte-
nance of a high glycolytic rate.26 In the HK-deficient
patient, the residual HK activity is bound also. How-
ever, the compensatory type III HK is found only in
the cytosol. It is not clear how these alterations affect
lymphocyte metabolism, but no functional abnormali-
ties could be found in the patient’s lymphocytes.
In the patient’s platelets HK was also deficient. No
compensation by type III HK was found, and most of
the activity was localized in the particulate fraction as
in normal platelets. The mutant properties of the
enzyme, in particular the decreased affinity for the
inhibitor glucose- 1,6-diphosphate, were also detected
in the platelet enzyme. Platelet aggregation induced by
0.1-5 U/ml thrombin was normal. In contrast, Ca2￿
secretion, as a reflection of dense granule release, was
slightly reduced. In the presence of the inhibitor of
mitochondnial ATP synthesis, antimycin-A (8.25 .tg/
ml) Ca2￿ secretion was more inhibited in the patient’s
platelets than in concurrently run normal subjects. The
discrepancy was even greater in the presence of both
antimycin-A and the glycogenolytic inhibitor, glucono-
t5-lactone. HK activity in the patient’s granulocytes
appeared to be normal. As the major isoenzyme in
normal human granulocytes is type III HK and the
activity and the electrophoretic pattern showed no
abnormalities (results not shown), we did not extend
our studies of HK to this blood cell type.
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